Ignite Creation Date:
2024-05-06 @ 9:24 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02978716
Status:
TERMINATED
Last Update Posted:
2022-03-23
First Post:
2016-11-18
Brief Title:
Trilaciclib G1T28 a CDK 46 Inhibitor in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer mTNBC
Sponsor:
G1 Therapeutics Inc
Organization:
G1 Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-18
First Submit QC Date:
November 28 2016
Study First Post Date:
2016-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-07-18
Disp First Submit QC Date:
February 24 2022
Disp First Post Date:
2022-03-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-02-24
Last Update Post Date:
2022-03-23
Last Update Post Date Type:
ACTUAL